Prenatal Screening for CMV Primary Infection: A Cost-Utility Model.

IF 4.7 4区医学 Q1 OBSTETRICS & GYNECOLOGY

Obstetrical & Gynecological Survey Pub Date : 2025-11-01 DOI:10.1097/01.ogx.0001172288.00818.27

Gebrael El Hachem, Christian Renaud, Catherine McCarey, Soren Gantt, Fatima Kakkar, Marc Sab, Thomas G Poder, Isabelle Boucoiran

引用次数: 0

Abstract

(Abstracted from BJOG 2025;132:805-815) Approximate 1 in 200 neonates in Canada is born with congenital cytomegalovirus (cCMV). CMV is an infection that can cause neurodevelopmental disability in children, including deafness, visual impairment, or cognitive delay.

查看原文本刊更多论文

巨细胞病毒原发感染的产前筛查：成本-效用模型。

（摘自BJOG 2025；132:805-815）在加拿大，大约每200名新生儿中就有1名先天性巨细胞病毒（cCMV）。巨细胞病毒是一种感染，可导致儿童神经发育障碍，包括耳聋、视力障碍或认知迟缓。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Obstetrical & Gynecological Survey 医学-妇产科学

CiteScore

2.70

自引率

3.20%

发文量

245

审稿时长

>12 weeks

期刊介绍： Each monthly issue of Obstetrical & Gynecological Survey presents summaries of the most timely and clinically relevant research being published worldwide. These concise, easy-to-read summaries provide expert insight into how to apply the latest research to patient care. The accompanying editorial commentary puts the studies into perspective and supplies authoritative guidance. The result is a valuable, time-saving resource for busy clinicians.